SLS BIO Co., Ltd (KOSDAQ:246250)
1,969.00
0.00 (0.00%)
At close: Oct 10, 2025
SLS BIO Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
Cash & Equivalents | 676.57 | 1,144 | 1,822 | 1,527 | 464.33 | 75.22 |
Short-Term Investments | 6,040 | 6,536 | 7,533 | 1,021 | 1,502 | - |
Cash & Short-Term Investments | 6,717 | 7,680 | 9,355 | 2,548 | 1,966 | 75.22 |
Cash Growth | -23.57% | -17.90% | 267.16% | 29.58% | 2514.23% | - |
Accounts Receivable | 1,182 | 1,786 | 1,982 | 3,029 | 3,004 | 2,461 |
Other Receivables | 29.98 | 46.06 | 66.78 | 5.35 | 10.55 | 7.11 |
Receivables | 1,212 | 1,833 | 2,049 | 3,034 | 3,023 | 2,481 |
Inventory | 173.37 | 173.37 | 260.85 | 307.2 | - | - |
Prepaid Expenses | 84.91 | 56.47 | 57.19 | 3.22 | 1.78 | 1.39 |
Other Current Assets | 18.31 | 46.47 | 28.67 | 166.03 | 88.93 | 30.14 |
Total Current Assets | 8,206 | 9,789 | 11,751 | 6,058 | 5,080 | 2,587 |
Property, Plant & Equipment | 4,795 | 4,740 | 4,173 | 4,084 | 1,417 | 1,235 |
Long-Term Investments | - | - | - | 42.14 | 64.12 | 67.12 |
Other Intangible Assets | 147.39 | 156.16 | 251.83 | 165.78 | 52.02 | 69.47 |
Long-Term Accounts Receivable | 0 | 0 | -0 | 123.78 | 0 | -0 |
Long-Term Deferred Tax Assets | 825.7 | 1,214 | 1,237 | 849.52 | 351.41 | 333.55 |
Long-Term Deferred Charges | - | - | - | - | 3,797 | 3,437 |
Other Long-Term Assets | 482.15 | 459.74 | 425.37 | 429.66 | 245.33 | 173.81 |
Total Assets | 14,456 | 16,359 | 17,838 | 11,753 | 11,007 | 7,903 |
Accounts Payable | 283.23 | 408.84 | 693.41 | 353.82 | 320.4 | 305.41 |
Accrued Expenses | 42.68 | 77.74 | 67.86 | 193.79 | 70.25 | 67.58 |
Short-Term Debt | - | - | - | - | 2,522 | 2,834 |
Current Portion of Long-Term Debt | - | - | - | - | 37.76 | 209.08 |
Current Portion of Leases | 631.05 | 561.43 | 568.26 | 565.64 | 121.64 | 176.5 |
Current Income Taxes Payable | - | - | - | - | 0.42 | 2.43 |
Other Current Liabilities | 214.18 | 426.44 | 406.21 | 930.14 | 949.51 | 679.42 |
Total Current Liabilities | 1,171 | 1,474 | 1,736 | 2,043 | 4,022 | 4,274 |
Long-Term Debt | - | - | - | - | 1,357 | 1,922 |
Long-Term Leases | 971.09 | 1,149 | 1,536 | 1,951 | 72.49 | 67.55 |
Other Long-Term Liabilities | 82.94 | 81.56 | 78.52 | 75.26 | 0 | -0 |
Total Liabilities | 3,340 | 3,845 | 4,371 | 5,048 | 6,025 | 6,716 |
Common Stock | 7,674 | 7,674 | 3,837 | 3,433 | 2,889 | 2,163 |
Additional Paid-In Capital | 1,290 | 1,290 | 5,155 | 201.8 | 3,137 | 247.44 |
Retained Earnings | 2,874 | 4,261 | 4,309 | 2,884 | -997.37 | -1,202 |
Treasury Stock | -899.88 | -899.88 | - | - | - | - |
Comprehensive Income & Other | 178.83 | 187.61 | 164.95 | 186.67 | -46.97 | -21.96 |
Shareholders' Equity | 11,117 | 12,513 | 13,466 | 6,705 | 4,982 | 1,187 |
Total Liabilities & Equity | 14,456 | 16,359 | 17,838 | 11,753 | 11,007 | 7,903 |
Total Debt | 1,602 | 1,710 | 2,105 | 2,517 | 4,111 | 5,209 |
Net Cash (Debt) | 5,115 | 5,970 | 7,250 | 30.98 | -2,144 | -5,134 |
Net Cash Growth | -26.30% | -17.66% | 23304.74% | - | - | - |
Net Cash Per Share | 335.85 | 390.54 | 515.69 | 4.52 | -430.00 | -1180.47 |
Filing Date Shares Outstanding | 15.05 | 15.05 | 15.35 | 6.81 | 4.99 | 4.35 |
Total Common Shares Outstanding | 15.05 | 15.05 | 15.35 | 6.81 | 4.99 | 4.35 |
Working Capital | 7,035 | 8,315 | 10,015 | 4,015 | 1,058 | -1,687 |
Book Value Per Share | 738.74 | 831.55 | 877.38 | 983.97 | 998.93 | 272.87 |
Tangible Book Value | 10,969 | 12,357 | 13,214 | 6,539 | 4,930 | 1,117 |
Tangible Book Value Per Share | 728.95 | 821.17 | 860.97 | 959.64 | 988.50 | 256.90 |
Machinery | 2,613 | 2,659 | 2,586 | 2,501 | 638.3 | 593.37 |
Construction In Progress | 781.06 | 749.57 | 113.61 | 71.17 | 70.72 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.